A61K 38/215
Ifn-beta
Official title: {IFN-beta}
A61K38/215 (Ifn-beta) appears on 418 US grants and 787 published applications in this corpus.
Search patents in A61K- Granted patents
- 418
- Published applications
- 787
- Assignees
- 334
- Inventors
- 1,239
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 5 | 0 |
| 1998 | 5 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 2 |
| 2002 | 5 | 13 |
| 2003 | 7 | 31 |
| 2004 | 5 | 30 |
| 2005 | 10 | 30 |
| 2006 | 7 | 28 |
| 2007 | 8 | 31 |
| 2008 | 16 | 41 |
| 2009 | 10 | 30 |
| 2010 | 14 | 32 |
| 2011 | 12 | 27 |
| 2012 | 23 | 30 |
| 2013 | 27 | 31 |
| 2014 | 20 | 46 |
| 2015 | 35 | 50 |
| 2016 | 29 | 45 |
| 2017 | 17 | 36 |
| 2018 | 15 | 26 |
| 2019 | 30 | 19 |
| 2020 | 15 | 24 |
| 2021 | 13 | 41 |
| 2022 | 11 | 33 |
| 2023 | 9 | 39 |
| 2024 | 19 | 25 |
| 2025 | 14 | 28 |
| 2026 | 5 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Targeting lung-resident TNFR2+ cDC2 (R2D2) subpopulation to treat asthma14 Jul 2026US 12,678,487 B2University of Florida Research Foundation, Inc.
- Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases2 Jun 2026US 12,642,817 B2The Johns Hopkins University
- Anti-IFNAR1 antibodies19 May 2026US 12,630,639 B2Immunecent Biotechnology, Inc.
- Aluminum based adjuvants for tolerogenic vaccination10 Mar 2026US 12,569,556 B2East Carolina University
- Compositions and methods related to tumor cell killers and vaccines20 Jan 2026US 12,527,821 B2The Brigham and Women S Hospital, Inc.
- Synthekine Compositions and Methods of Use10 Sep 2026US 2026/0263562 A1The Board of Trustees of the Leland Stanford Junior University
- Dry powder formulation of interferon beta and method for preparing same6 Aug 2026US 2026/0224666 A1Abion Inc.
- Pharmaceutical Composition for Treating or Preventing Cancer Comprising Inhibitor of NUTM1 and Anticancer Agent as Active Ingredients and Use Thereof6 Aug 2026US 2026/0224731 A1
- Molecular indexing of proteins by self assembly (mipsa) for efficient proteomic investigations23 Jul 2026US 2026/0209391 A1The Johns Hopkins University
- Use of antiviral agents, composition of matter, combination preparations/agents to treat chronic diseases associated with epstein-barr virus and other human herpes viruses9 Jul 2026US 2026/0191871 A1
Most cited
By later US patents
- Solubilization of proteins for pharmaceutical compositions using polymer conjugation538US 4,766,106 ACetus Corporation · 1988
- Interleukin-2 muteins and polymer conjugation thereof444US 5,206,344 ACetus Oncology Corporation · 1993
- Spray drying of macromolecules to produce inhaleable dry powders220US 6,582,728 B1Inhale Therapeutic Systems · 2003
- Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins198US 9,303,079 B2Moderna Therapeutics, Inc. · 2016
- Process for preparing micronized polypeptide drugs174US 5,354,562 ASRI International · 1994